These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 26089029

  • 1. Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system.
    Muller ME, Forni Ogna V, Maillard M, Stoudmann C, Zweiacker C, Anex C, Wuerzner G, Burnier M, Bonny O.
    Pflugers Arch; 2015 Dec; 467(12):2413-21. PubMed ID: 26089029
    [Abstract] [Full Text] [Related]

  • 2. Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism.
    Kawata T, Imanishi Y, Kobayashi K, Kenko T, Wada M, Ishimura E, Miki T, Nagano N, Inaba M, Arnold A, Nishizawa Y.
    Eur J Endocrinol; 2005 Oct; 153(4):587-94. PubMed ID: 16189180
    [Abstract] [Full Text] [Related]

  • 3. Acute activation of the calcium-sensing receptor inhibits plasma renin activity in vivo.
    Atchison DK, Ortiz-Capisano MC, Beierwaltes WH.
    Am J Physiol Regul Integr Comp Physiol; 2010 Oct; 299(4):R1020-6. PubMed ID: 20660105
    [Abstract] [Full Text] [Related]

  • 4. Intact parathyroid hormone and whole parathyroid hormone assay results disagree in hemodialysis patients under cinacalcet hydrochloride therapy.
    Koda R, Kazama JJ, Matsuo K, Kawamura K, Yamamoto S, Wakasugi M, Takeda T, Narita I.
    Clin Exp Nephrol; 2015 Aug; 19(4):710-7. PubMed ID: 25384431
    [Abstract] [Full Text] [Related]

  • 5. Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
    Brown JM, Williams JS, Luther JM, Garg R, Garza AE, Pojoga LH, Ruan DT, Williams GH, Adler GK, Vaidya A.
    Hypertension; 2014 Feb; 63(2):273-80. PubMed ID: 24191286
    [Abstract] [Full Text] [Related]

  • 6. The effects of piretanide on catecholamine metabolism, plasma renin activity and plasma aldosterone: a double-blind study versus furosemide in healthy volunteers.
    Verho M, Heintz B, Nelson K, Kirsten R.
    Curr Med Res Opin; 1985 Feb; 9(7):461-74. PubMed ID: 3896657
    [Abstract] [Full Text] [Related]

  • 7. A novel calcimimetic agent, evocalcet (MT-4580/KHK7580), suppresses the parathyroid cell function with little effect on the gastrointestinal tract or CYP isozymes in vivo and in vitro.
    Kawata T, Tokunaga S, Murai M, Masuda N, Haruyama W, Shoukei Y, Hisada Y, Yanagida T, Miyazaki H, Wada M, Akizawa T, Fukagawa M.
    PLoS One; 2018 Feb; 13(4):e0195316. PubMed ID: 29614098
    [Abstract] [Full Text] [Related]

  • 8. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
    Block GA, Bushinsky DA, Cheng S, Cunningham J, Dehmel B, Drueke TB, Ketteler M, Kewalramani R, Martin KJ, Moe SM, Patel UD, Silver J, Sun Y, Wang H, Chertow GM.
    JAMA; 2017 Jan 10; 317(2):156-164. PubMed ID: 28097356
    [Abstract] [Full Text] [Related]

  • 9. Study of the effects of cicletanine on the renin-angiotensin-aldosterone system.
    Bippi H, Guinot P.
    Drugs Exp Clin Res; 1988 Jan 10; 14(2-3):215-20. PubMed ID: 3046885
    [Abstract] [Full Text] [Related]

  • 10. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Circ Heart Fail; 2009 Nov 10; 2(6):532-40. PubMed ID: 19919977
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery.
    Bernini G, Moretti A, Lonzi S, Bendinelli C, Miccoli P, Salvetti A.
    Metabolism; 1999 Mar 10; 48(3):298-300. PubMed ID: 10094103
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of furosemide and ACTH on plasma renin, aldosterone and cortisol levels in normal man].
    Cénac A, London A, Ménard J, Corvol P.
    Ann Endocrinol (Paris); 1975 Mar 10; 36(3):153-62. PubMed ID: 172005
    [Abstract] [Full Text] [Related]

  • 18. Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects.
    Ichihara A, Suzuki H, Saruta T.
    J Lab Clin Med; 1993 Oct 10; 122(4):432-40. PubMed ID: 8228558
    [Abstract] [Full Text] [Related]

  • 19. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and water-sodium-calcium metabolism in patients with essential hypertension.
    Iimura O, Kikuchi K, Shimamoto K, Nozawa A, Hasegawa R, Homma C, Komura H, Kobayakawa H.
    Arzneimittelforschung; 1989 Jun 10; 39(6):710-4. PubMed ID: 2775339
    [Abstract] [Full Text] [Related]

  • 20. Calcium modulation of the renin-aldosterone axis.
    Porter L, Conlin PR, Scott J, Brown EM, El-Hajj Fuleihan G.
    J Endocrinol Invest; 1999 Feb 10; 22(2):115-21. PubMed ID: 10195378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.